(Q44105608)

29 November 2017

title

The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study (English)

1 reference

29 November 2017

0 references

Melek N Yavuz

1

1 reference

29 November 2017

A Aydin Yavuz

2

1 reference

29 November 2017

Fazil Aydin

3

1 reference

29 November 2017

Gamze Can

4

1 reference

29 November 2017

Halil Kavgaci

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

International Journal of Radiation Oncology Biology Physics

29 November 2017

published in

1 reference

29 November 2017

volume

54

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

195-202

1 reference

Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Long-term results of octreotide-therapy in severe dumping syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Octreotide in the management of treatment-related diarrhoea.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Octreotide acetate in refractory bone marrow transplant-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Octreotide in the treatment of severe chemotherapy-induced diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Somatostatin attenuates ischemic intestinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

1 reference

7 January 2021

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Morphologic response of the mucosa of human small intestine to x-ray exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Radiation injuries of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

The Franz Buschke lecture: Late effects of chemotherapy and radiation therapy: A new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Morphometric analysis of the effects of antineoplastic drugs on mucosa of normal ileum and ileal anastomoses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

The role of luminal contents in radiation enteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Diarrhea in terminally ill patients: Pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Somatostatin analogues suppress the inflammatory reaction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Multiple G-protein-dependent pathways mediate the antisecretory effects of somatostatin and clonidine in the HT29-19A colonic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

Response to increasing doses of octreotide in a patient with carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902870-5

7 January 2021

10.1016/S0360-3016(02)02870-5

Identifiers

DOI

1 reference

29 November 2017

1 reference